Document Type : Original Article
Authors
1 Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
2 Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences , Kerman, Iran
3 Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Objective: Coronavirus disease 2019 (COVID-19) is an infection which can present itself by
the involvement of various organs, but the most common manifestations are respiratory
symptoms, fever and dyspnea with a high mortality rate. In order to study the prognosis of
patients and also to determine the treatment plan, we need non-invasive methods which
can be easily used in the triage of patients. In this study, we investigated the diagnostic
value of electrocardiographic (ECG) changes and troponin levels in patients with this
disease.
Methods: This is a descriptive study. Confirmed COVID-19 patients participated in the
present study. Data were collected by taking history and referring to medical records. We
analyzed data by using chi square, t test and logistic regression through SPSS software
version 22.
Results: One hundred and five patients with COVID-19 disease were examined. Most
patients were men (53.3%) and the mean age was 54.53 years. The most common underlying
diseases were hypertension and diabetes mellitus. Ninety-five patients had abnormal
electrocardiography including eleven with long QT; seven with arrhythmia; 78 with sinus
tachycardia; 7 with hemi-block; 1 with hemi-block and first degree atrioventricular block;
4 with abnormal axis and 28 with ischemic changes. Eleven patients (10.5%) had positive
troponin level, whose length of hospital stay was higher (12.73 vs. 12.07 days). Furthermore,
their mean length of intensive care unit (ICU) stay was also higher. In addition, among the
troponin-positive group, 100% had abnormal electrocardiography.
Conclusion: The findings of the present study showed that ECG abnormalities and troponin
levels could provide good information about the prognosis of patients. Moreover, it seems
that ECG changes in COVID-19 patients, whether indicative of underlying heart disease or
resulted from infection, can affect the prognosis of patients. Therefore, considering ECG
findings and troponin levels can help select patients at a higher risk for triage.
Keywords
Main Subjects
s1047951120001821.
2. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020; 38(7): 1504-7. doi: 10.1016/j.ajem.2020.04.048.
3. Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, et al. COVID-19 pandemic: cardiovascular complications and future implications. Am J Cardiovasc Drugs 2020; 20(4): 311-24. doi: 10.1007/s40256-020-00420-2.
4. He J, Wu B, Chen Y, Tang J, Liu Q, Zhou S, et al. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol 2020; 36(6): 966.e1-966.e4. doi: 10.1016/j.cjca.2020.03.028.
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet 2020; 395(10223): 497-506. doi:10.1016/s0140-6736(20)30183-5.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel
coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061-9. doi: 10.1001/jama.2020.1585.
7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with
COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-62. doi: 10.1016/s0140-
6736(20)30566-3.
8. Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated troponin in patients with coronavirus disease 2019: possible mechanisms. J Card Fail 2020; 26(6): 470-5. doi: 10.1016/j.cardfail.2020.04.009.
9. Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G, et al. Electrocardiographic features of patients
with COVID-19 pneumonia. Eur J Intern Med 2020; 78: 101-6. doi: 10.1016/j.ejim.2020.06.015.
10. Yang Z, Shi J, He Z, Lü Y, Xu Q, Ye C, et al. Predictors for imaging progression on chest CT from coronavirus disease
2019 (COVID-19) patients. Aging (Albany NY) 2020; 12(7): 6037-48. doi: 10.18632/aging.102999.
11. Mann D, Zipes D, Libby P, Bonow R. Braunwalds Heart Disease: A Textbook of Cardiovascular Medicine. Saunders:
Elsevier; 2015.
12. McCullough SA, Goyal P, Krishnan U, Choi JJ, Safford MM, Okin PM. Electrocardiographic findings in coronavirus
disease-19: insights on mortality and underlying myocardial processes. J Card Fail 2020; 26(7): 626-32. doi: 10.1016/j.
cardfail.2020.06.005.
13. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for
patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75(18):
2352-71. doi: 10.1016/j.jacc.2020.03.031.
14. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients
with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5(7): 811-8. doi: 10.1001/jamacardio.2020.1017.
15. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an
analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94(7): e00127-20. doi: 10.1128/
jvi.00127-20.
16. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis 2020; 63(3): 390-1. doi: 10.1016/j.pcad.2020.03.001.
17. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients
with COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5(7): 802-10. doi: 10.1001/jamacardio.2020.0950.
18. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109(5): 531-8.doi: 10.1007/s00392-020-01626-9.
19. Pishgahi M, Yousefifard M, Safari S, Ghorbanpouryami F. Electrocardiographic findings of COVID-19 patients and their correlation with outcome; a prospective cohort study. Front Emerg Med 2020; 5(2): e17. doi: 10.18502/fem.v5i2.5608.
20. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3. doi:10.1038/s41586-020-2012-7.
21. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8(4): e21. doi: 10.1016/s2213-2600(20)30116-8.
22. Khajali Z, Sanati HR, Pouraliakbar H, Mohebbi B, Aeinfar K, Zolfaghari R. Self-expandable stent for repairing
coarctation of the left-circumferential aortic arch with right-sided descending aorta and aberrant right subclavian
artery with Kommerell’s aneurysm. Ann Vasc Surg 2017; 38: 318.e7-318.e10. doi: 10.1016/j.avsg.2016.05.116.
)